Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor accessory protein 1 (REEP1) is a membrane-associated protein found predominantly in neuronal cells of the brain and spinal cord. It plays a crucial role in shaping and maintaining the structure of the endoplasmic reticulum (ER), particularly the formation of tubular ER networks critical for axonal health and maintenance. REEP1 also enhances the trafficking and cell surface expression of certain G protein–coupled receptors, such as odorant and taste receptors, by facilitating their delivery through the ER. REEP1 localizes to both the ER and mitochondria, and may act at ER-mitochondria junctions to facilitate organelle communication and homeostasis. Mutations in REEP1 are causative for several neurodegenerative conditions, primarily hereditary spastic paraplegia type 31 (SPG31), which is characterized by progressive weakness and spasticity of the lower limbs due to degeneration of upper motor neurons. Pathogenic variants disrupt ER morphology, compromise axonal maintenance, and can negatively affect energy metabolism by altering the ER-mitochondria interface. REEP1 is not currently a direct therapeutic target, but it is central to the pathophysiology of these inherited neurodegenerative diseases.
Not applicable (REEP1 is not a target of drugs; it acts as an accessory/trafficking and membrane-shaping protein rather than as a direct mediator of pharmacological action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor accessory protein 1 (REEP1).